Clinical Trials Directory

Trials / Completed

CompletedNCT06975098

A Journey to Balance: Development and Validation of Individualized Life Balance Intervention for Depression

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
11 (actual)
Sponsor
Chung Shan Medical University · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical intervention study is to enhance life balance in community-dwelling individuals with depression. The main question it aims to answer is: Can an individualized life balance intervention, combining group sessions and telephone support, effectively improve life balance, time management, functional roles, quality of life, and reduce depression severity in individuals with depression? Participants will: Complete baseline assessments including demographics, illness-related information, and the Canadian Occupational Performance Measure (COPM). Participate in four weekly, two-hour group sessions tailored to their individual needs identified through the COPM assessment. Receive telephone support 1-3 days before each group session. Complete post-intervention assessments immediately after the four-week program and again one month later.

Conditions

Interventions

TypeNameDescription
OTHERLife balance intervention group programLife balance intervention group program is a four-week group intervention program for individuals with depression, with sessions lasting two hours each week. The program will address life balance issues such as daily scheduling, time management, stress coping, emotional regulation, and social participation, and will be tailored to individual patient needs. Through group discussions and practical exercises, participants will learn to apply these skills in their daily lives. Telephone support will be provided during the intervention period to offer emotional support and enhance participation rates.

Timeline

Start date
2024-09-23
Primary completion
2025-01-13
Completion
2025-06-30
First posted
2025-05-16
Last updated
2025-08-13

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT06975098. Inclusion in this directory is not an endorsement.